Showing results (411-420 of 903) with videos related to

Sort By:
Pageof 91
Gastroenterology|May 20, 2008
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cellsBastian Hoechst, Lars A Ormandy, Matthias Ballmaier, et al.
Oncoimmunology|November 22, 2012
Primary sterile necrotic cells fail to cross-prime CD8(+) T cellsJaba Gamrekelashvili, Lars A Ormandy, Markus M Heimesaat, et al.
The Journal of Infectious Diseases|May 29, 2016
Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV InfectionPatrick Behrendt, Birgit Bremer, Daniel Todt, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|April 4, 2002
Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled studyUlrich Stölzel, Detlef Schuppan, Hans L Tillmann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2010
Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCCTim F Greten, Lars A Ormandy, Annika Fikuart, et al.
The Journal of Infectious Diseases|May 6, 2010
How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocidesSandra Ciesek, Martina Friesland, Jörg Steinmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
Meganuclease-mediated virus self-cleavage facilitates tumor-specific virus replicationEngin Gürlevik, Peter Schache, Anneliese Goez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 10, 2013
Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detectionHarald Schrem, Marlene Kurok, Alexander Kaltenborn, et al.
Journal of Clinical Microbiology|March 31, 2010
Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kineticsIngmar Mederacke, Birgit Bremer, Benjamin Heidrich, et al.
The Lancet. Infectious Diseases|March 6, 2019
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trialHeiner Wedemeyer, Cihan Yurdaydin, Svenja Hardtke, et al.
Pageof 91